We are live on ! Find out more
HCM

Highbridge Capital Management Portfolio holdings

AUM $3.09B
1-Year Est. Return 31.21%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+31.21%
3 Year Est. Return
+54.52%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.37%
AUM
$2.45B
AUM Growth
+$45M
Cap. Flow
-$1.31B
Cap. Flow %
-53.22%
Top 10 Hldgs %
43.27%
Holding
417
New
29
Increased
24
Reduced
15
Closed
57

Sector Composition

Rank Sector Weight
1 Communication Services 5.01%
2 Healthcare 1.66%
3 Utilities 0.76%
4 Technology 0.39%
5 Real Estate 0.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLEUW
226
DELISTED
bleuacacia ltd Warrants
BLEUW
0
GLLIW
227
DELISTED
Globalink Investment Inc. Warrants
GLLIW
0
OSRHW
228
OSR Health Warrant
OSRHW
0
CSTA.WS
229
DELISTED
Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CSTA.WS
0
SPECW
230
DELISTED
Spectaire Holdings, Inc. Warrant
SPECW
0
CNGLW
231
DELISTED
Canna-Global Acquisition Corp Warrant
CNGLW
0
SHAP.WS
232
DELISTED
Spree Acquisition Corp. 1 Limited Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
SHAP.WS
0
EVE.WS
233
DELISTED
EVe Mobility Acquisition Corp Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
EVE.WS
0
DPCSW
234
DELISTED
DP Cap Acquisition Corp I Warrants
DPCSW
0
GBBKW
235
DELISTED
Global Blockchain Acquisition Corp. Warrant
GBBKW
0
ADTHW
236
DELISTED
AdTheorent Holding Co Warrants
ADTHW
0
ESLAW icon
237
Estrella Immunopharma Warrant
ESLAW
$138K
0
PIIIW icon
238
P3 Health Partners Inc Warrant
PIIIW
$179K
0
CSLMW
239
DELISTED
CSLM Acquisition Corp. Warrant
CSLMW
0
CEROW
240
DELISTED
CERo Therapeutics Warrants
CEROW
0
LSBPW
241
DELISTED
LakeShore Biopharma Warrants
LSBPW
0
GAQ.WS
242
DELISTED
Generation Asia I Acquisition Limited Redeemable Warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
GAQ.WS
0
KYCHR
243
DELISTED
Keyarch Acquisition Corporation Rights
KYCHR
$10.2K ﹤0.01%
175,587
TRONW
244
DELISTED
Corner Growth Acquisition Corp. 2 Warrants
TRONW
0
GRRRW
245
Gorilla Technology Group Warrant
GRRRW
$1.82M
0
PEGRW
246
DELISTED
Project Energy Reimagined Acquisition Corp. Warrant
PEGRW
0
CETUW
247
DELISTED
Cetus Capital Acquisition Corp. Warrant
CETUW
0
HCMAW
248
DELISTED
HCM Acquisition Corp Warrant
HCMAW
0
NUVB.WS
249
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
0
MCAAW
250
DELISTED
Mountain & Co. I Acquisition Corp. Warrant
MCAAW
0

Similar funds

Highbridge Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Highbridge Capital Management held 417 positions worth $2.45B, up 1.9% from $2.41B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Highbridge Capital Management withdrew a net $1.31B in Q4 2023, closing 57 positions and reducing 15 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $19.3M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 5% of assets, up from 4.6% a quarter earlier, followed by Healthcare and Utilities.

Against the trend, Highbridge Capital Management opened a new position in Capri Holdings worth $8.29M.

  • Highbridge Capital Management's largest Q4 2023 buy was Capri Holdings: 165,000 shares worth $8.29M.
  • Highbridge Capital Management added most to Amedisys in Q4 2023, an estimated $14.5M increase.
  • Highbridge Capital Management's biggest Q4 2023 reduction was Brookdale Senior Living Inc. 7.00% Tangible Equity Units, cutting an estimated $14M.
  • Highbridge Capital Management fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $19.3M.
  • Highbridge Capital Management's ten largest holdings make up 43% of its $2.45B portfolio in Q4 2023.
  • Highbridge Capital Management opened 29 new positions and closed 57 in Q4 2023.
  • Highbridge Capital Management's portfolio value rose 1.9% quarter-over-quarter to $2.45B.

Based on Highbridge Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.